Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Repos Pharma AB
AB
Active
Org 5569461956
Bredgränd 14, 753 20
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Repos Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
EE
Erika Elisabeth Kjellberg Eriksson
External Signatory
External Signatory
2024
SM
Sven Mårten Fryknäs
Chief Executive Officer
Chief Executive Officer
2022
Former (1)
CA
Cecilia Anna Karin Johansson
Audit
Audit
2022 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
HP
Hans Peter Nygren
Board of Directors
Board of Directors
2022
AS
Angelica Sara Ingrid Loskog
Chairman
Chairman
2022
RL
Rolf Lennart Larsson
Board of Directors
Board of Directors
2022
SM
Sven Mårten Fryknäs
Board of Directors
Board of Directors
2022
Shareholders
As of last annual report
Nexttobe AB — 77%
77%
Shareholder
Type
Ownership
Votes
Since
Nexttobe AB
Company
77%
77%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Repos Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network